Figures & data
EGFR, epidermal growth factor receptor gene; ALK, anaplastic lymphoma receptor kinase gene; ROS1, ROS proto-oncogene 1, receptor tyrosine kinase; BRAF, B-Raf proto-oncogene, serine/threonine kinase; NTRK, Neurotrophic tyrosine receptor kinase gene; HER2, human epidermal growth factor receptor 2 gene; MET, MET proto-oncogene; RET, RET proto-oncogene; KRAS, KRAS proto-oncogene; PD-L1, programmed death-ligand 1.
NGS, next-generation sequencing; SST, sequential single testing; EGFR, epidermal growth factor receptor gene; ALK, anaplastic lymphoma receptor kinase gene; ROS1, ROS proto-oncogene 1, receptor tyrosine kinase; BRAF, B-Raf proto-oncogene, serine/threonine kinase; NTRK, neurotrophic tyrosine receptor kinase gene; MET, MET proto-oncogene; RET, RET proto-oncogene; KRAS, KRAS proto-oncogene; PD-L1, programmed death-ligand 1* HER2 is not shown as its testing rate is 0%, as shown in .
Supplemental material